In the BioHarmony Drug Report Database
Fanapt (iloperidone) is a small molecule pharmaceutical. Iloperidone was first approved as Fanapt on 2009-05-06. It is used to treat schizophrenia and schizophrenia spectrum and other psychotic disorders in the USA. It is known to target 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 7, and D(2) dopamine receptor. Fanapt’s patents are valid until 2031-12-28 (FDA).
Image (chem structure or protein)